Pherecydes Pharma S.A.
PAR: ALPHE.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Thibaut du Fayet
- Employees
- 29
- Headquarters
- Romainville, France
- IPO year
- 2021
- Market cap
- €15.8M
- Website
- https://www.pherecydes-pharma.com
Loading ALPHE…
Loading profile data…Frequently asked questions about ALPHE
What does Pherecydes Pharma S.A. (ALPHE.PA) do?
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infecti...
Where does ALPHE.PA trade?
Pherecydes Pharma S.A. (ALPHE.PA) trades on the Euronext Paris.
What sector is ALPHE.PA in?
Pherecydes Pharma S.A. (ALPHE.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pherecydes Pharma S.A.?
Thibaut du Fayet is the chief executive officer of Pherecydes Pharma S.A. (ALPHE.PA).
Where is Pherecydes Pharma S.A. headquartered?
Pherecydes Pharma S.A. is headquartered in France.
Does ALPHE.PA pay a dividend?
Pherecydes Pharma S.A. (ALPHE.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALPHE.PA go public?
Pherecydes Pharma S.A. (ALPHE.PA) completed its initial public offering in 2021.